UK Viscosupplementation Market Size & Outlook, 2023-2030
UK viscosupplementation market, 2018-2030 (US$M)
Related Markets
UK viscosupplementation market highlights
- The UK viscosupplementation market generated a revenue of USD 82.6 million in 2023 and is expected to reach USD 164.8 million by 2030.
- The UK market is expected to grow at a CAGR of 10.4% from 2024 to 2030.
- In terms of segment, single injection was the largest revenue generating product in 2023.
- Single Injection is the most lucrative product segment registering the fastest growth during the forecast period.
Viscosupplementation market data book summary
| Market revenue in 2023 | USD 82.6 million |
| Market revenue in 2030 | USD 164.8 million |
| Growth rate | 10.4% (CAGR from 2023 to 2030) |
| Largest segment | Single injection |
| Fastest growing segment | Single Injection |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Injection, Three Injection, Five Injection |
| Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Other key industry trends
- In terms of revenue, UK accounted for 1.7% of the global viscosupplementation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, France viscosupplementation market is projected to lead the regional market in terms of revenue in 2030.
- France is the fastest growing regional market in Europe and is projected to reach USD 270.0 million by 2030.
Single injection was the largest segment with a revenue share of 43.58% in 2023. Horizon Databook has segmented the UK viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
Prevalence of osteoarthritis in the UK is high with almost 8.75 million people suffering from the same in 2013. According to a report published by Arthritis Research UK in 2013, arthritis and musculoskeletal conditions affected around 10 million people across the country and were responsible for spending an NHS program budget of 5 billion euro.
The regulations are stringent, but UK has also approved viscosupplements for other parts of body, such as shoulder and hip. This contributes to the increasing market share of the region. In addition, favorable healthcare programs in the country may further drive the market of viscosupplements.
For instance, Biosport Project focuses on development of innovative biomedical techniques and technologies to address musculoskeletal injuries. It has mentioned the use of viscosupplements as an innovative biotherapy for repair and regeneration of musculoskeletal injuries.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Viscosupplementation Market Scope
Viscosupplementation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK viscosupplementation market size, by product, 2018-2030 (US$M)
UK Viscosupplementation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
